EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel pH‐Responsive Structural Rearrangement of Myristic Acid‐Conjugated Quetiapine Nanosuspension for Enhanced Long‐Acting Delivery Performance

Hy Dinh Nguyen, Hai Van Ngo, Beom-Jin Lee iD

Advanced Science · 2024

DOI: 10.1002/advs.202405200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Hy Dinh Nguyen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Pharmacy, Ajou University, Suwon, 16499, Republic of Korea. Hauptthemen laut MEDLINE: Quetiapine Fumarate, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT, NRF Grant and Commercialization Promotion Agency for R&D Outcomes (COMPA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quetiapine myristate (QM), an ester‐bonded lipophilic prodrug of quetiapine (QTP), is synthesized and converted into an amphiphilic structure in acidic pH to trigger a novel self‐assembled QM nanosuspension (QMN). Following injection, this QMN rearranges within physiological pH to form nanoaggregates in structure, resulting in enhanced physicochemical properties and in vivo therapeutic performance without an initial burst release. The 200‐nm‐sized QMN exhibits less invasive injection, higher drug content, and better storage stability profile than conventional poly(lactide‐co‐glycolide) (PLGA) nanosuspensions containing QTP or QM. Following a single intramuscular injection to beagle dogs (35 mg kg −1 QTP), QMN undergoes pH‐responsive nanoaggregation to form the lipophilic prodrug, providing esterase‐oriented sustained release for five weeks compared with the two‐week period of PLGA nanosuspensions. Notably, QMN exhibits improved in vivo pharmacokinetic performance with long‐acting delivery while minimizing issues associated with polymeric PLGA formulations, including the initial massive burst release, cellular toxicity, and adverse side effects. These results support the further development of QMN as a novel long‐acting injectable to improve patient compliance and dosing frequency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quetiapine FumarateNanoparticlesAnimalsDogsHydrogen-Ion ConcentrationDelayed-Action PreparationsDrug Delivery SystemsSuspensionsMale

Stichwörter der Autor:innen

initial burst releaselong‐acting injectablesnanoaggregatespH‐responsive structural rearrangementquetiapine myristateself‐assembled nanoparticles

Substanzen

Quetiapine FumarateDelayed-Action PreparationsSuspensions

Autor:innen und Institutionen

  • Department of Pharmacy, College of Pharmacy, Ajou University, Suwon, 16499, Republic of Korea.
  • Institute of Pharmaceutical Science and Technology, Ajou University, Suwon, 16499, Republic of Korea.

ORCID-Profile: Beom-Jin Lee

Förderung

  • National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT
  • NRF Grant and Commercialization Promotion Agency for R&D Outcomes (COMPA)

Zitieren

APA

Nguyen, H. D., Ngo, H. V., & Lee, B. J. (2024). Novel pH‐Responsive Structural Rearrangement of Myristic Acid‐Conjugated Quetiapine Nanosuspension for Enhanced Long‐Acting Delivery Performance. Advanced Science. https://doi.org/10.1002/advs.202405200

Vancouver

Nguyen HD, Ngo HV, Lee BJ. Novel pH‐Responsive Structural Rearrangement of Myristic Acid‐Conjugated Quetiapine Nanosuspension for Enhanced Long‐Acting Delivery Performance. Advanced Science. 2024. doi:10.1002/advs.202405200

BibTeX
@article{Nguyen2024,
  author = {Nguyen, Hy Dinh and Ngo, Hai Van and Lee, Beom-Jin},
  title = {Novel pH‐Responsive Structural Rearrangement of Myristic Acid‐Conjugated Quetiapine Nanosuspension for Enhanced Long‐Acting Delivery Performance},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202405200}
}
Kostenlos starten →